Upstream Bio Inc

NEW
NAS:UPB (USA)  
$ 7.62 -0.43 (-5.34%) 12:08 AM EST
At Loss
P/B:
0.86
Market Cap:
$ 408.74M
Enterprise V:
$ -59.87M
Volume:
291.36K
Avg Vol (2M):
239.83K
Trade In:
What is a stock summary page? Click here for an overview.
Volume:
291.36K
At Loss
Avg Vol (2M):
239.83K

Business Description

Description
Upstream Bio Inc is a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders. It is developing verekitug, the known antagonist currently in clinical development that targets the receptor for Thymic Stromal Lymphopoietin (TSLP), a cytokine that is a clinically validated driver of inflammatory response positioned upstream of multiple signaling cascades that affect a variety of immune-mediated diseases.
Name Current Vs Industry Vs History
Cash-To-Debt 256.52
Equity-to-Asset 0.98
Debt-to-EBITDA -0.04
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 20.76
Distress
Grey
Safe
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 25.43
9-Day RSI 36.12
14-Day RSI 39.14
3-1 Month Momentum % -50.77

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 44.63
Quick Ratio 44.63
Cash Ratio 43.82
Days Sales Outstanding 136.73

Dividend & Buy Back

Name Current Vs Industry Vs History
Shareholder Yield % -0.45

Financials

UPB's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:UPB

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016

Upstream Bio Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 1.22
EPS (TTM) ($) -0.806
Beta -
3-Year Sharpe Ratio -
3-Year Sortino Ratio -
Volatility % -
14-Day RSI 39.14
14-Day ATR ($) 0.88546
20-Day SMA ($) 8.448
12-1 Month Momentum % -
52-Week Range ($) 6.65 - 29.4599
Shares Outstanding (Mil) 53.64

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Upstream Bio Inc Filings

Filing Date Document Date Form
No Filing Data

Upstream Bio Inc Stock Events

Financials Calendars
Event Date Price ($)
No Event Data

Upstream Bio Inc Frequently Asked Questions

What is Upstream Bio Inc(UPB)'s stock price today?
The current price of UPB is $7.62. The 52 week high of UPB is $29.46 and 52 week low is $6.65.
When is next earnings date of Upstream Bio Inc(UPB)?
The next earnings date of Upstream Bio Inc(UPB) is .
Does Upstream Bio Inc(UPB) pay dividends? If so, how much?
Upstream Bio Inc(UPB) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1